Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of CinnaGen-liraglutide (Melitide) vs Victoza in Type 2 Diabetes
NCT03421119Phase 3Unknown
- Sponsor
- CinnaGen
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Peptides
01
Overview
A Phase 3 trial of Melitide in type 2 diabetes mellitus (T2DM), sponsored by CinnaGen. Status: unknown.
02
Drugs
Melitide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03421119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421119.